and spiders what are the next steps in ensuring bm is ...c.ymcdn.com/sites/ · pdf file ......
TRANSCRIPT
Melissa Ruble, Pharm.D., BCPS Assistant Professor University of South Florida College of Pharmacy
http://fluoridedetective.com/wp-content/uploads/2011/07/Doctor-Patient.jpg
I have nothing to disclose
Upon completion of this program, pharmacists will be able to
Analyze the six basic steps to approaching a poisoned patient Classify toxidromes using clinical signs and symptoms Demonstrate an understanding of common xenobiotics and their antidotes Formulate treatment plans for common overdose patients Describe common clinical presentations and treatment strategies of bites and envenomation including snakes and spiders
Upon completion of this program, pharmacy technicians will be able to
Identify the six basic steps to approaching a poisoned patient Classify toxidromes using clinical signs and symptoms Demonstrate an understanding of common xenobiotics and their antidotes Describe common clinical presentations and treatment strategies of bites and envenomation including snakes and spiders
BM is a 33 yo male who is found wandering the streets chasing a man he says owes him money. He appears altered and anxious. He is profusely sweating and yelling for a man named “Skinny” Pete. The police apprehend him and find blue methamphetamine in his pocket. As the police question him he begins to complain of chest pain and falls to the ground unresponsive. EMS is called immediately and he is brought emergently into your ED. What are the next steps in ensuring BM is treated appropriately?
1.Stabilization 2.Patient evaluation/diagnosis 3.Decontamination 4.Antidotes 5.Elimination enhancement 6.Continuous care/disposition
Brief examination to identify necessary measurements in preventing further deterioration of the patient CAB
Circulation/compressions Airway Breathing
Altered mental status Other complications
Check blood pressure, pulse rate, and rhythm If no pulse start CPR – ACLS
Begin ECG monitoring Check for arrhythmias, QT prolongation, QRS prolongation
Obtain IV/IO access ICU patients require two 18 gauge
Start fluids NS is fluid of choice for adults 5% dextrose in ¼ normal saline is used in children
Check for gag reflex Glascow coma scale (GCS) less than 8 INTUBATE!
Optimize the airway position Place neck and head in the sniffing position Apply jaw thrust to force the flaccid tongue forward Head-down, left-sided position ▪Allows tongue to fall forward and secretions to drain out of
mouth Remove any obstruction or secretions by suctioning
http://medipptx.blogspot.com/2010/07/airway-management_4650.html
Respiratory failure Failure of ventilatory muscles ▪Paralysis (neuromuscular blockers, botulinum toxin, organophosphates,
snakebites, warfare nerve gases) Central depression of respiratory drive ▪Antihistamines, barbiturates, clonidine, ethanol, opioids, TCAs Severe pneumonia/pulmonary edema Obtain arterial blood gases (ABG) ▪Estimate the adequacy of ventilation from pCO2 levels
▪> 60 mm Hg indicates a need for assisted ventilation Hypoxia/Hypercarbia
Brain damage, cardiac arrest, acidosis, dysrhythmias Administer supplemental oxygen as indicated ▪Consider hyperbaric oxygen (carbon monoxide poisoning)
Bronchospasms Administer supplemental oxygen as indicated
AMS can be accompanied by respiratory depression and thus airway is evaluated prior to CNS changes Maintain airway and assist ventilation when necessary Naloxone administration
All patients with respiratory depression should receive naloxone
Check blood sugar EMS and immediate bedside glucose determination Administer concentrated glucose if necessary ▪Adults 50% dextrose – 25g IV ▪Children 25% dextrose – 2 mL/kg IV
Check body (rectal) temperature If head trauma obtain CT scan If suspected meningitis or encephalitis, perform lumbar puncture Treat seizures
Benzodiazepines Control agitation
Sedatives (benzodiazepines, atypical antipsychotics)
Rhabdomyolysis Muscle cell necrosis is a common complication of poisoning Aggressively hydrate patient Alkalinize the urine by adding sodium bicarbonate to fluids Provide hemodialysis if needed
Allergy Dystonia/rigidity
Check for track marks, trauma
History Detailed physical examination Laboratory tests Toxin identification
Toxidrome
Frequently unreliable or incomplete Multiple xenobiotics
Ask patient what they took, how many, time of ingestion Ask family, friends, EMS about medications known to be used by the patient or found at the scene If information is available, call patient’s pharmacy to determine whether other prescription medications may have been taken
EFORCE
Autonomic physical examination Blood pressure Pulse rate Pupils ▪Size ▪Nystagmus Skin ▪Diaphoresis, pale, cyanosis Peristalsis
Neuropathy Odors
Cyanide – bitter almond Arsenic, organophospates – garlic Methyl salicylate - wintergreen
Electrolytes Serum glucose BUN/SCr LFTs CBC Urinalysis
ECG Serum acetaminophen, salicylate, and ethanol level Pregnancy test Serum osmolality Drug levels when necessary – phenytoin, digoxin
Skin Wear protective gear and wash exposed areas promptly Contact regional poison center for information about the hazards of the chemicals involved Remove contaminated clothing and flush exposed areas with copious amounts of lukewarm water or saline
Eyes Flush eyes with lukewarm water or saline ▪Remove contact lenses
Inhalant Remove victim from exposure Observe for upper respiratory tract edema ▪Assist ventilation when necessary
GI Controversial ▪Little support in the medical literature for gut-emptying procedures ▪Studies have shown that after 60 minutes very little of the ingested
dose is removed by emesis or gastric lavage Activated charcoal ▪Highly adsorbent powdered material ▪Large surface area – adsorbs most toxins when given in a 10 to 1
ratio (charcoal to toxin) ▪Many times it comes mixed with sorbitol ▪Dose – 1 g/kg Whole-bowel irrigation ▪Polyethylene glycol ▪High flow rates to wash intestinal contents
Administered after identification of specific agent or signs and symptoms of agents without contraindications Naloxone is recommended in any patient who presents with CNS depression Become familiar with antidotes and dosing as this is an emergency situation
Know where to find contraindications and monitoring parameters during treatment
Supportive care Seizure precautions Vomiting
Three critical questions to ask yourself Does the patient need enhanced removal? ▪Severe or critical intoxication with deteriorating condition despite
maximal supportive care ▪Normal or usual route of elimination impaired (hepatic or renal
failure) ▪Ingestion of lethal dose or lethal blood level Is the drug or toxin accessible to be removed? ▪Volume of distribution
▪Large Vd has very low plasma concentrations and will not be removed with HD
▪Protein binding ▪High protein binding makes it difficult to remove by dialysis
Will the method work? ▪Does the removal procedure efficiently extract the toxin from the
blood?
Urinary manipulation Relies on renal clearance of medication Alkalize the urine Especially helpful for salicylate poisoning
Hemodialysis What type of medications will this work for?
Activated charcoal If overdose is known to have been less than 1 hour Increased risk of aspiration if AMS
Adequate observation Usually a 6 hour minimal observation period Close monitoring requires ICU
Poison prevention consultation Determine need for further evaluation Educate patients on prevention especially if pediatrics are involved
Psychiatric counseling Baker act if intentional
Referral for follow-up treatment Specialists – cardio, renal, psych, OB
Definition Derived from the words toxic syndrome Group of signs and symptoms that are associated with exposure to a particular substance or class of substance Described by a combination of vital signs and clinically apparent end-organ manifestations
Central Nervous System (CNS)
Mental status Ophthalmic system
Pupil size Mucous membrane
Moist vs. dry
Gastrointestinal system Peristalsis
Genitourinary Urine retention vs. incontinence
Dermatology Skin dryness vs. diaphoresis
ALWAYS remember that the actual clinical manifestations of a poisoning are variable Most useful when looking at clinical presentation and preparing a framework for assessment Incomplete toxidromes may still provide clues to correct diagnosis
Be a detective! Partial presentations DO NOT imply less-severe disease
Anticholinergics Cholinergics Ethanol or sedative hypnotics Opioids Sympathomimetics
https://www.google.com/url?sa=i&rct=j&q=&esrc=s&source=images&cd=&cad=rja&uact=8&ved=0CAYQjB0&url=http%3A%2F%2Fwww.cartoonstock.com%2Fdirectory%2Fo%2Foverdosed.asp&ei=AlnhVIa7L4yyggTV5YDIDA&bvm=bv.85970519,d.cWc&psig=AFQjCNGSnOq1C17IOOn3hIheGonlanvK-w&ust=1424140793968334
BP P RR T Mental Status Pupils Peristalsis Diaphoresis
-/
±
Delirium
BP P RR T Mental Status
Pupils Peristalsis Diaphoresis
± ±
-/
- Normal to depressed
±
DUMBBELLS SLUDGE
BP P RR T Mental Status
Pupils Peristalsis Diaphoresis Other
-/
Depressed agitated
±
- Hyporeflexia, ataxia
BP P RR T Mental Status
Pupils Peristalsis Diaphoresis Other
Depressed
- Hyporeflexia
BP P RR T Mental Status
Pupil size
Peristalsis Diaphoresis Other
Agitated
-/
Tremor, seizure
56 yo agitated female is brought into the ED restrained by EMS. The patient is tachycardic, with an elevated core temperature, mydriasis, and delirium. Upon further assessment you notice a decrease in peristalsis and signs of dehydration. What toxidrome are you suspecting?
JR is a 32 yo male who is brought in by his girlfriend. He is very lethargic with pin point pupils (miosis). His blood pressure is 80/40 and pulse is 50. His respiratory rate is 8 breaths/min and he is having trouble keeping his airway. Upon further evaluation you notice he has decreased peristalsis. What toxidrome are you suspecting?
NT is a 19 yo female who presents to the ED via EMS with increased blood pressure, pulse, respiratory rate, and temperature. She is very agitated and must be restrained by 4 officers. Her pupils are dilated and she is sweating profusely. What toxidrome are you suspecting?
LW is a 68 yo male who presents to the ED with is wife. She states he has been sweating more than usual all day. He has had severe diarrhea for the past several hours, salivating more than normal, urinating often, and keeps coughing up phlegm. What toxidrome are you suspecting?
A 24-year-old man with a long-standing history of drug use (cocaine, alcohol) is admitted to the ED with a suspected cocaine overdose. His BP is 210/115 mm Hg. His laboratory values are within normal limits except for SCr 2.4 mg/dL and K 5.2 mEq/L. The patient’s cardiac enzymes are normal. In addition to a benzodiazepine, which one of the following agents would be the best recommendation for this patient? Why?
A.Sodium nitroprusside B.Esmolol C.Labetalol D.Nicardipine
Case adapted from ACCP Flip Cards Pharmacotherapy
Drug overdose (OD) was the leading cause of injury death in 2012
More than doubled from 1999 to 2013 81% of drug OD deaths were unintentional
Patients unaware of max doses/combination medications
Of the 43,982 drug OD deaths in 2013, 71.3% involved opioids and 30.6% involved benzodiazepines
Centers for Disease Control and Prevention (CDC). http://www.cdc.gov/media/releases/2013/p0220_drug_overdose_deaths.html
Men were 59% more likely than women to die Whites had highest death rate
American Indians/Alaska Natives Blacks
Age 45-49 years
Centers for Disease Control and Prevention (CDC). http://www.cdc.gov/homeandrecreationalsafety/overdose/facts.html
Clinically used to treat both acute or chronic pain Available in various formulations
Epidural, inhalation, intranasal, intrathecal, oral, parenteral (SC, IV, IM), rectal, transdermal, and transmucosal
Has both euphoric and addictive potentials
Estimated that 69,000 people die from opioid overdose each year
15 million people suffer from opioid dependence Derived from opium poppy or synthetic analogues with similar effects
Examples: morphine, heroin, tramadol, oxycodone and methadone
Opioid triad Pinpoint pupils, unconsciousness, respiratory depression
World Health Organization (WHO). http://www.who.int/substance_abuse/information-sheet/en/
People with opioid dependence Especially patients following detoxicication, incarceration, cessation of treatment
People who inject opioids People taking high doses of opioids People with medical conditions such as HIV, liver or lung disease, depression
World Health Organization (WHO). http://www.who.int/substance_abuse/information-sheet/en/
Appearance White or brownish powder Black sticky substance “black tar heroin”
Physical symptoms “toxidrome” Euphoria, drowsiness (CNS depression), respiratory depression, miosis, nausea, and dry mouth
SAMHSA. http://www.samhsa.gov/atod/opioids
CAB Supportive care Antidote Labs Continuous care
Monitoring
Opioid antagonist at all receptors (U, K, D) Mechanism
Prevents action of opioid receptors Reverses effects of both endogenous and exogenous opioids Causes opioid withdrawal in opioid dependent patients
Nelson LS. Goldfrank's Toxicologic Emergencies. 10th ed. 2014. http://accesspharmacy.mhmedical.com
Dosing 0.4 – 2 mg IV Dependent patient dose: 0.04 IV Repeat every 3 minutes until improved respirations
Does the dose matter? Increased risk for acute withdrawal symptoms ▪Aspiration, pain, agitation
Goal is NOT complete arousal but to provide adequate spontaneous ventilation
ALWAYS use lowest dose initially IV NOT SC due to unpredictable onset
Nelson LS. Goldfrank's Toxicologic Emergencies. 10th ed. 2014. http://accesspharmacy.mhmedical.com
Long acting opioids Heroin is short acting so should not be used
Body packers Recommended dosing
2/3 initial reversal dose per hour Titrate per clinical presentation Confusing protocols
Nelson LS. Goldfrank's Toxicologic Emergencies. 10th ed. 2014. http://accesspharmacy.mhmedical.com
Retail (street-level) heroin always contains adulterants Historically quinine and strychnine used
Mimic bitter taste of heroin Cardiac arrhythmias
1995 – scopolamine Acute psychosis, anticholinergic crisis
2005 – Clenbuterol (B2-adrenergic agonist) Tachycardia, hypotension, hypokalemia
Nelson LS. Goldfrank's Toxicologic Emergencies. 10th ed. 2014. http://accesspharmacy.mhmedical.com
Inhalation of white pyrolysate Pharmacokinetics similar to IV Avoids injection drug use
Fentanyl Regional epidemics of substitution for heroin Super potent activity ▪Dramatic increase in deaths
Higher doses of naloxone may be necessary
Desomorphine 15 x more potent than morphine
Heroin substitute Less expensive Easily manufactured ▪Two-step synthetic process
Contaminated with corrosive by-products or residuals
Responsible for undesired or toxic effects
Katselou M, et al. Life Sci. 2014 May 2;102(2):81-7.
True or false Naloxone comes as a prescription for patients to administer at home that is interactive to prevent overdose in chronic opioid/high risk patients?
First synthesized as nasal decongestant Later used to treat narcolepsy
Supplied as stimulants to soldiers and prisoners of war in World War II 1980’s use increased and derivatives MDMA and MDEA were produced
“Ice” Easy to produce and low cost
Sympathomimetics – “toxidrome” Hyperadrenergic state Amphetamine > cocaine in duration of action
Acidosis Rhabdomyolysis Status epilepticus
Direct result or secondary from hyponatremia Hyperthermia – CNS alterations Intracerebral hemorrhage/cerebral infarct
CAB IV access
Sedation Benzodiazepines, propofol
Hydration and cooling Labs
CK, lactate Supportive care
Historically adulterants were inert Starches, sympathomimetic agents, local anesthetics
Levamisole Antihelminthic immunomodulator Withdrawn from market due to agranulocytosis 2009 over 69% of cocaine contained levamisole Patient presentation ▪Neutropenia, agranulocytosis, vasculitis, and purpura
JP is a 26 yo male who presents to the ED following a binge use of cocaine. He is complaining of anhedonia and lethargy. He is having trouble initiating and sustaining movement. He is cognitively intact. Is this normal and if so what is the term? Washed – out syndrome
Also known as Ecstasy, Adam, Beans, and Rolls Stimulant/Psychoactive agent Thought to be the “pure MDMA”
Infrequently found to contain MDMA Other chemicals such as methylone are also sold under this name Typically contains 1+ stimulants
https://www.google.com/url?sa=i&rct=j&q=&esrc=s&source=images&cd=&cad=rja&uact=8&ved=0CAYQjB0&url=http%3A%2F%2Fwww.emirates247.com%2Foffbeat%2Fthis-is-life%2Fparents-pass-on-irrational-fear-of-spiders-and-snakes-to-children-2011-01-26-1.347411&ei=xyjgVLKgKIbFggS8qoHIBw&bvm=bv.85970519,d.eXY&psig=AFQjCNEGmemXsSW-tiIKXaR7qenxUNM5BQ&ust=1424062038341526
JD is a 56 yo male who has been drinking for the past few hours with his friends. As he was walking to his car to get his next case of beer, when he notices a snake on the ground. He calls his friends over and they decide to play “who can catch the snake first”. Being the competitive person he is, JD dives at the snake and grabs him by what he thought was the head. Instead he grabs the tail and ends up getting bit by the rattlesnake. His friends laugh at first but then panic and decide to bring him in to your ED. Where do you start?
VENOMOUS
Southern copperhead Cottonmouth, Water moccasin Eastern diamondback rattlesnake Timber rattlesnake Dusky pigmy Eastern coral snake
NON-VENOMOUS
Eastern rat snake, yellow rat snake Florida water snake Kingsnake Black racer
http://www.flmnh.ufl.edu/herpetology/fl-snakes/venomous-snakes
Peak number of bites in July Men comprise of 75% of cases
Children represent 10-15% Over half of reported bites occur when individual is purposefully handling the snake Herpetologists are at highest risk
Mark leading edge of swelling every 15-30 minutes Immobilize and elevate extremity Treat pain Obtain initial lab studies
PT/INR, Hgb, platelets, fibrinogen Update tetanus vaccine Contact poison control center (1-800-222-1222)
Swelling, tenderness, redness Elevated PT/INR Decreased fibrinogen or platelets Systemic signs
Hypotension, excessive bleeding, refractory vomiting, diarrhea, angioedema, neurotoxicity
BTG International Inc. http://www.supplements.annemergmed.com/PDF/Treatment-Algorithm.pdf
Establish IV access and provide fluids Mix 4 to 6 vials of crotaline Fab antivenom (CroFab®) in 250 mL NS
Infuse over 1 hour Re-examine patient for response within 1 hour
If initial control is not achieved, repeat dose of antivenom
BTG International Inc. http://www.supplements.annemergmed.com/PDF/Treatment-Algorithm.pdf
Perform serial examinations Consider maintenance antivenom therapy Observe patient for 18 – 24 hours after initial control Labs 6 – 12 hours after initial control and prior to discharge
BTG International Inc. http://www.supplements.annemergmed.com/PDF/Treatment-Algorithm.pdf
Do NOT administer antivenom Observe the patient for at least 8 hours Repeat labs prior to discharge If patient develops signs of envenomation, then check for indications for antivenom and proceed
BTG International Inc. http://www.supplements.annemergmed.com/PDF/Treatment-Algorithm.pdf
Live in temperate and tropical latitudes Stone walls, crevices, wood piles, outhouses, barns, stables
Classic red hourglass-shaped marking is noted in only L. mactans
Pinprick when bitten Pair of red spots at site (uncommon)
Systemic toxicity Neuromuscular symptoms within 30 – 60 minutes Progressive pain
Sweating, contorted/grimaced face, muscle cramping, hypertension
Laboratory data is not helpful in the management Leukocytosis and CKP elevations are mostly found but do not predict outcomes
CAB Support respirations when indicated
Wound evaluation Tetanus prophylaxis
Pain management Grade 1 – cold packs/NSAIDS Grade 2 and 3 – IV opioids and benzodiazepines
Risk of anaphylaxis and serum sickness Latrodectus antivenom
Rapidly effective and curative Reserved for severe reaction and designated as a grade 3
1 to 2 vials in 50 – 100 mL 5% dextrose or 0.9% NS infused over 1 hour
Antivenoms in the works Analatro ▪Less chance of anaphylaxis
Evaluation of a poisoned patient should be thorough, systematic, and performed quickly It is important to understand the mechanisms of toxicity and recognize the signs and symptoms of presenting patients Many times toxicity occurs quickly and supportive care and administration of an antidote in a timely manner is crucial Pharmacists play an essential role in identifying toxicities, monitoring patients, and dosing medications in ALL poisoned patients
Hoffman RS, Howland M, Lewin NA, Nelson LS, Goldfrank LR. Principles of Managing the Acutely Poisoned or Overdosed Patient. In: Hoffman RS, Howland M, Lewin NA, Nelson LS, Goldfrank LR. eds. Goldfrank's Toxicologic Emergencies, 10e. New York, NY: McGraw-Hill; 2015.http://accesspharmacy.mhmedical.com.ezproxy.hsc.usf.edu/content.aspx?bookid=1163&Sectionid=65089354. Accessed February 15, 2015.. Hoffman R.S., Nelson L.S., Goldfrank L.R., Howland M, Lewin N.A., Flomenbaum N.E.(2011). Chapter 3. Initial Evaluation of the Patient: Vital Signs and Toxic Syndromes. In Nelson L.S., Lewin N.A., Howland M, Hoffman R.S., Goldfrank L.R., Flomenbaum N.E.(Eds), Goldfrank's Toxicologic Emergencies, 9e . Retrieved March 15, 2014 fromhttp://accesspharmacy.mhmedical.com.ezproxy.hsc.usf.edu/content.aspx?bookid=454&Sectionid=40199367. Chyka P.A. (2011). Chapter 14. Clinical Toxicology. In DiPiro J.T., Talbert R.L., Yee G.C., Matzke G.R., Wells B.G., Posey L (Eds), Pharmacotherapy: A Pathophysiologic Approach, 8e. Retrieved March 15, 2014 fromhttp://accesspharmacy.mhmedical.com.ezproxy.hsc.usf.edu/content.aspx?bookid=462&Sectionid=41100780.
Olson KR. Chapter 1. Emergency Evaluation and Treatment. In: Olson KR. eds.Poisoning & Drug Overdose, 6e. New York, NY: McGraw-Hill; 2012.http://accessmedicine.mhmedical.com.ezproxy.hsc.usf.edu/content.aspx?bookid=391&Sectionid=42069814. Accessed February 15, 2015. Hoffman R.S., Nelson L.S., Goldfrank L.R., Howland M, Lewin N.A., Flomenbaum N.E.(2011). Chapter 3. Initial Evaluation of the Patient: Vital Signs and Toxic Syndromes. InNelson L.S., Lewin N.A., Howland M, Hoffman R.S., Goldfrank L.R., Flomenbaum N.E.(Eds), Goldfrank's Toxicologic Emergencies, 9e . Retrieved March 15, 2014 fromhttp://accesspharmacy.mhmedical.com.ezproxy.hsc.usf.edu/content.aspx?bookid=454&Sectionid=40199367. Denshaw-Burke M. (2013). Methemoglobinemia. Medscape. Retrieved from http://emedicine.medscape.com/article/204178-overview Katselou M, Papoutsis I, Nikolaou P, et al. A “Krokodil” emerges from the murky waters of addiction. Abuse trends of an old drug. Life Sci. 2014; 102 (2); 81-7. doi: 10.1016/j.lfs.2014.03.008 Hahn I. Arthropods. In: Hoffman RS, Howland M, Lewin NA, Nelson LS, Goldfrank LR. eds. Goldfrank's Toxicologic Emergencies, 10e. New York, NY: McGraw-Hill; 2015.http://accesspharmacy.mhmedical.com.ezproxy.hsc.usf.edu/content.aspx?bookid=1163&Sectionid=65101715. Accessed February 18, 2015.